Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Items 201–300 of 1,000
Anandhan, A., Jacome, M. S., Lei, S., Hernandez-Franco, P., Pappa, A., Panayiotidis, M. I., Powers, R., & Franco, R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.009 · Cited by 162
Mitochondrial Dysfunction in Parkinson's Disease
Keane, P. C., Kurzawa, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson's Disease · doi:10.4061/2011/716871 · Cited by 160
Periquet, M., Corti, O., Jacquier, S., & Brice, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03442.x · Cited by 160
C6ORF66 Is an Assembly Factor of Mitochondrial Complex I
Saada, A., Edvardson, S., Rapoport, M., Shaag, A., Amry, K., Miller, C., Lorberboum-Galski, H., & Elpeleg, O. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.08.003 · Cited by 159
Mitochondrial Dysfunction in Parkinson's Disease
Zhu, J., & Chu, C. T. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100363 · Cited by 158
Mitochondrial dynamics and mitophagy in lung disorders
Sharma, A., Ahmad, S., Ahmad, T., Ali, S., & Syed, M. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119876 · Cited by 158
Genetic mouse models of Parkinson’s disease
Magen, I., & Chesselet, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84004-x · Cited by 156
Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Higgins, G. C., Beart, P. M., Shin, Y. S., Chen, M. J., Cheung, N. S., & Nagley, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100321 · Cited by 156
Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., García de Yébenes, J., & Mena, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03777.x · Cited by 156
Parkin-associated Parkinson’s disease
von Coelln, R., Dawson, V. L., & Dawson, T. M. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0924-4 · Cited by 156
Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease
Luoma, P. T., Eerola, J., Ahola, S., Hakonen, A. H., Hellström, O., Kivistö, K. T., Tienari, P. J., & Suomalainen, A. (2007) · Neurology · doi:10.1212/01.wnl.0000276955.23735.eb · Cited by 154
Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts
Puri, R., Cheng, X.-T., Lin, M.-Y., Huang, N., & Sheng, Z.-H. (2019) · Nature Communications · doi:10.1038/s41467-019-11636-5 · Cited by 154
Autophagy protects the retina from light-induced degeneration
Chen, Y., Sawada, O., Kohno, H., Le, Y.-Z., Subauste, C., Maeda, T., & Maeda, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.439935 · Cited by 152
Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts
Grünewald, A., Voges, L., Rakovic, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann, K., Orolicki, S., Ramirez, A., Schapira, A. H. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012962 · Cited by 152
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Reeve, A. K., Grady, J. P., Cosgrave, E. M., Bennison, E., Chen, C., Hepplewhite, P. D., & Morris, C. M. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0044-6 · Cited by 152
Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 153
What causes the death of dopaminergic neurons in Parkinson’s disease?
Surmeier, D. J., Guzmán, J. N., Sánchez-Padilla, J., & Goldberg, J. A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83004-3 · Cited by 152
Hu, X., Weng, Z., Chu, C. T., Zhang, L., Cao, G., Gao, Y., Signore, A., Zhu, J., Hastings, T., Greenamyre, J. T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4589-10.2011 · Cited by 149
Mitochondrial Contribution to Parkinson's Disease Pathogenesis
Schapira, A. H. V., & Gegg, M. (2011) · Parkinson's Disease · doi:10.4061/2011/159160 · Cited by 146
Molecular Pathology of Lewy Body Diseases
Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 148
A Mitocentric View of Parkinson's Disease
Haelterman, N. A., Yoon, W. H., Sandoval, H., Jaiswal, M., Shulman, J. M., & Bellen, H. J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014317 · Cited by 144
Etiology and Pathogenesis of Parkinson Disease
Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 150
Lu, X., Altshuler-Keylin, S., Wang, Q., Chen, Y., Henrique Sponton, C., Ikeda, K., Maretich, P., Yoneshiro, T., & Kajimura, S. (2018) · Science Signaling · doi:10.1126/scisignal.aap8526 · Cited by 143
“Although genetic deletion of Park2 is insufficient to cause a Parkinson’s disease phenotype in mice (26, 27), Park2 knockout mice (referred to as Park2 KO mice) are resistant to body weight gain under a highfat diet, partially because of reduced lipid uptake by the fatty acid transporter CD36 (28, 29).”
BackgroundMitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 145
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., & Goldberg, J. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3521 · Cited by 143
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 142
Keating, D. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04997.x · Cited by 141
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & García de Yébenes, J. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 141
Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress
Janda, E., Isidoro, C., Carresi, C., & Mollace, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8318-1 · Cited by 140
Mitochondrial dynamics in Parkinson's disease
Van Laar, V. S., & Berman, S. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 140
Wang, H., Ni, H., Chao, X., Ma, X., Rodriguez, Y., Chavan, H. D., Wang, S., Krishnamurthy, P. C., Dobrowsky, R. T., Xu, D., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101148 · Cited by 140
Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 142
Drosophila models pioneer a new approach to drug discovery for Parkinson's disease
Whitworth, A. J., Wes, P. D., & Pallanck, L. J. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03693-7 · Cited by 140
Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 142
Kazlauskaite, A., Kelly, V., Johnson, C., Baillie, C., Hastie, C. J., Peggie, M., Macartney, T., Woodroof, H. I., Alessi, D. R., Pedrioli, P. G. A., et al. (2014) · Open Biology · doi:10.1098/rsob.130213 · Cited by 139
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 138
Exploiting Oxidative Microenvironments in the Body as Triggers for Drug Delivery Systems
Joshi-Barr, S., Lux, C. D. G., Mahmoud, E., & Almutairi, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5754 · Cited by 138
Apoptosis and its Role in Parkinson’s Disease
Erekat, N. S. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch4 · Cited by 137
Mitochondrial turnover in the heart
Gottlieb, R. A., & Gustafsson, Å. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.017 · Cited by 136
Genetics of Parkinson's disease
Gasser, T. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.3/tgasser · Cited by 136
Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease
Giannoccaro, M. P., La Morgia, C., Rizzo, G., & Carelli, V. (2017) · Movement Disorders · doi:10.1002/mds.26966 · Cited by 135
Liu, W., Vives-Bauza, C., Acín-Peréz-, R., Yamamoto, A., Tan, Y., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004597 · Cited by 135
Parkin and relatives: the RBR family of ubiquitin ligases
Marín, I., Lucas‐Lledó, J. I., Gradilla, A., & Ferrús, A. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00226.2003 · Cited by 137
Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
Calì, T., Ottolini, D., & Brini, M. (2011) · BioFactors · doi:10.1002/biof.159 · Cited by 134
Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
Trempe, J.-F., & Fon, E. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00038 · Cited by 133
How does parkin ligate ubiquitin to Parkinson's disease?: First in Molecular Medicine Review Series
Kahle, P. J., & Haass, C. (2004) · EMBO reports · doi:10.1038/sj.embor.7400188 · Cited by 133
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease
Pacelli, C., Rasmo, D. D., Signorile, A., Grattagliano, I., Tullio, G. D., D’Orazio, A., Nico, B., Comi, G. P., Ronchi, D., Ferranini, E., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.022 · Cited by 133
Animal Models of Parkinson's Disease: A Gateway to Therapeutics?
Le, W., Sayana, P., & Jankovic, J. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0234-1 · Cited by 134
Mitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Zaman, V., Shields, D. C., Shams, R., Drasites, K. P., Matzelle, D. D., Haque, A., & Banik, N. L. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00689-5 · Cited by 132
Targeting urate to reduce oxidative stress in Parkinson disease
Crotty, G. F., Ascherio, A., & Schwarzschild, M. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.017 · Cited by 130
Chandran, J. S., Lin, X. Z., Zapata, A. G., Höke, A., Shimoji, M., Moore, S. O., Galloway, M. P., Laird, F. M., Wong, P. C., Price, D. L., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.011 · Cited by 127
Setsuie, R., Wang, Y.-L., Mochizuki, H., Osaka, H., Hayakawa, H., Ichihara, N., Li, H., Furuta, A., Sano, Y., Sun, Y., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.07.015 · Cited by 131
Impaired dopamine release and synaptic plasticity in the striatum of Parkin−/− mice
Kitada, T., Pisani, A., Karouani, M., Haburcak, M., Martella, G., Tscherter, A., Platania, P., Wu, B., Pothos, E. N., & Shen, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06152.x · Cited by 125
Self-citationHan, R., Liang, J., & Zhou, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115887 · Cited by 125
Paterna, J.-C., Leng, A., Weber, E., Feldon, J., & Büeler, H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300067 · Cited by 125
Role of Parkin and endurance training on mitochondrial turnover in skeletal muscle
Chen, C. C. W., Erlich, A. T., & Hood, D. A. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0157-y · Cited by 124
“Consistent with this, we found that KO mice exhibited reduced glutamate-ADP-stimulated state mitochondrial respiration, a result that was found in previous studies [70].”
ResultAlternative mitochondrial quality control mediated by extracellular release
Choong, C., Okuno, T., Ikenaka, K., Baba, K., Hayakawa, H., Koike, M., Yokota, M., Doi, J., Kakuda, K., Takeuchi, T., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1848130 · Cited by 124
Shen, J., & Cookson, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.012 · Cited by 124
Self-citationPerfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 124
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 125
Drosophila Models of Parkinson's Disease
Whitworth, A. J. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380860-8.00001-x · Cited by 123
Rial, D., Castro, A. A., Machado, N., Garção, P., Gonçalves, F. Q., Silva, H. B., Tomé, Â. R., Köfalvi, A., Corti, O., Raisman-Vozari, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114216 · Cited by 122
Mitophagy and reactive oxygen species interplay in Parkinson’s disease
Xiao, B., Kuruvilla, J., & Tan, E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00402-y · Cited by 124
van der Merwe, C., Dashti, Z. J. S., Christoffels, A. G., Loos, B., & Bardien, S. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12872 · Cited by 121
The Ubiquitin–Proteasome System in Retinal Health and Disease
Campello, L., Esteve-Rudd, J., Cuenca, N., & Martín‐Nieto, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8391-5 · Cited by 121
An emerging role of PARK2 in cancer
Xu, L., Lin, D., Yin, D., & Koeffler, H. P. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1107-0 · Cited by 120
Kagan, V. E., Wipf, P., Stoyanovsky, D., Greenberger, J. S., Borisenko, G., Belikova, N. A., Yanamala, N., Samhan Arias, A. K., Tungekar, M. A., & Jiang, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.008 · Cited by 119
Parkin: a multifaceted ubiquitin ligase
Moore, D. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340749 · Cited by 118
Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 120
Multifaceted deaths orchestrated by mitochondria in neurones
Nagley, P., Higgins, G. C., Atkin, J. D., & Beart, P. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.004 · Cited by 117
Glial Dysfunction in Parkin Null Mice: Effects of Aging
Solano, R. M., Casarejos, M. J., Menéndez-Cuervo, J., Rodriguez-Navarro, J. A., García de Yébenes, J., & Mena, M. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4609-07.2008 · Cited by 117
Laar, V. S. V., Dukes, A. A., Cascio, M., & Hastings, T. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.007 · Cited by 120
Aslanukov, A., Bhowmick, R., Guruju, M. R., Oswald, J., Raz, D., Bush, R. A., Sieving, P. A., Lu, X., Bock, C. B., & Ferreira, P. A. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020177 · Cited by 117
Parkinson’s disease: oxidative stress and therapeutic approaches
Surendran, S., & Rajasankar, S. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0245-1 · Cited by 113
Non‐motor behavioural impairments in parkin‐deficient mice
Zhu, X., Maskri, L., Herold, C., Bader, V., Stichel, C. C., Güntürkün, O., & Lübbert, H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05812.x · Cited by 112
Springer, W., Hoppe, T., Schmidt, E., & Baumeister, R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi371 · Cited by 112
Strey, C. W., Spellman, D. S., Stieber, A., Gonatas, J. O., Wang, X., Lambris, J. D., & Gonatas, N. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63426-8 · Cited by 111
Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & De Strooper, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100345 · Cited by 111
Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression
Grand, J. N. L., González-Cano, L., Pavlou, M. A. S., & Schwamborn, J. C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1774-1 · Cited by 112
Roca-Agujetas, V., Barbero-Camps, E., de Dios, C., Podlesniy, P., Abadin, X., Morales, A., Marí, M., Trullàs, R., & Colell, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00435-6 · Cited by 111
Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
Arboleda, G., Morales, L. C., Benítez, B. A., & Arboleda, H. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.10.001 · Cited by 111
Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms
Evans, C. S., & Holzbaur, E. L. F. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.031 · Cited by 110
Helley, M., Pinnell, J. R., Sportelli, C., & Tieu, K. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00177 · Cited by 110
Tyynismaa, H., Sun, R. X., Ahola, S., Almusa, H., Pöyhönen, R., Korpela, M., Honkaniemi, J., Isohanni, P., Paetau, A. E., Wang, L., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr438 · Cited by 109
Parkin is required for exercise-induced mitophagy in muscle: Impact of aging
Chen, C. C. W., Erlich, A. T., Crilly, M. J., & Hood, D. A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2017 · Cited by 108
Mitochondrial redox system, dynamics, and dysfunction in lung inflammaging and COPD
Lerner, C. A., Sundar, I. K., & Rahman, I. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.026 · Cited by 108
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Taylor, J. P., Mata, I. F., & Farrer, M. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.004 · Cited by 108
Parkinsonism genes: culprits and clues
Abeliovich, A., & Flint Beal, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04102.x · Cited by 107
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.026 · Cited by 108
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 105
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's Disease
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 105
A Mitochondrial Etiology of Neurodegenerative Diseases: Evidence from Parkinson's Disease
Khusnutdinova, E., Gilyazova, I., Ruiz‐Pesini, E., Derbeneva, O., Khusainova, R., Khidiyatova, I., Magzhanov, R., & Wallace, D. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.001 · Cited by 105
Chin, M. H., Qian, W., Wang, H., Petyuk, V., Bloom, J. S., Sforza, D., Laćan, G., Liu, D., Khan, A. H., Cantor, R. M., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr070546l · Cited by 105
L-Arginine and Nitric Oxide in CNS Function and Neurodegenerative Diseases
Virarkar, M., Alappat, L., Bradford, P. G., & Awad, A. B. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.573885 · Cited by 104
Unravelling mitochondrial pathways to Parkinson's disease
Celardo, I., Martins, L. M., & Gandhi, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12433 · Cited by 103
Islam, F., Nafady, M. H., Islam, M. R., Saha, S., Rashid, S., Akter, A., Harun-Or-Rashid, M., Akhtar, M. F., Perveen, A., Ashraf, G. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02859-7 · Cited by 102
New Developments in Genetic rat models of Parkinson's Disease
Creed, R. B., & Goldberg, M. S. (2018) · Movement Disorders · doi:10.1002/mds.27296 · Cited by 103
Self-citationMitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Trancikova, A. K., Tsika, E., & Moore, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4200 · Cited by 100
Zhong, N., & Xu, J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn230 · Cited by 99
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.